investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Toxicity Monitoring on Phase III Trials with Administrative Data
Richard Aplenc
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Lillian Sung
Hospital for Sick Children
Toronto, Canada
Richard Aplenc
Children's Hospital of Philadelphia
Philadelphia, United States
Related projects
Aaron D Schimmer
Targeting Mitochondrial Protein Synthesis with Tigecycline for the Treatment of l
Leukaemia
Hematology and hematologic malignancies
Theresa E Hahn
Genetic susceptibility to acute lymphocytic and myeloid leukemia
Leukaemia
Pediatric oncology or childhood cancer
Robert M Williams
Multiple Myeloma and Cancer Therapies via Largazole Analogs
Leukaemia
Hematology and hematologic malignancies
Clark W Distelhorst
Bcl-2 Function on the Endoplasmic Reticulum
Leukaemia
Hematology and hematologic malignancies
David A Fruman
TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance
Leukaemia
Hematology and hematologic malignancies
Crystal Mackall
Clinical Trials of Immunotherapies for Childhood Cancer
Leukaemia
Pediatric oncology or childhood cancer
Susan L Slager
Genetic Epidemiology Of Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies
Rainer F Storb
Hematopoietic Chimerism after Stem Cell Allografts
Leukaemia
Hematology and hematologic malignancies
Catherine Ju-Ying Wu
(PQD1) Impact of Cytotoxic and Targeted Therapy on Clonal Evolution of CLL
Leukaemia
Hematology and hematologic malignancies
